ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JIP YOON M.D.

Internal Medicine

1,390

$79.5K

68
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

57%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

RADHARANI GOLLAMUDI M.D.

Internal Medicine

1,391

$53.8K

366
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $61

MICHAEL DUBOIS MD

Internal Medicine

1,396

$88.8K

89
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

DANA COATES D.O.

Internal Medicine

1,403

$88.1K

248
192 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $61

MATHEW ABRAHAM MD

Internal Medicine

1,403

$76.6K

185
102 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

CHINTAN AMIN MD

Internal Medicine

1,404

$84.7K

123
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

JESSE SPEAR M.D.

Internal Medicine

1,404

$98.8K

136
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $61

ANGEL WILSON MD

Internal Medicine

1,418

$99.1K

151
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $61

AZARIAS LONBERGER M.D.

Internal Medicine

1,423

$82.3K

170
68 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

MARCELLA TASHJIAN-GIBBS M,D,

Internal Medicine

1,427

$79.7K

210
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $61

STEVEN JOHNSON D.O.

Internal Medicine

1,433

$58.7K

155
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $61

RANDALL LEE M.D.

Internal Medicine

1,445

$95.1K

94
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $61

TIMOTHY BRADY MD

Internal Medicine

1,449

$89K

72
36 are 65+

26%
patients receiving schedule two controlled substances

Avg: 6%

35%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

MOHAMMED MAJID MD

Internal Medicine

1,452

$100K

116
61 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $61

JAMES LEWIS MD

Internal Medicine

1,462

$97.7K

138
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $61

STEPHEN POLLOM M.D.

Internal Medicine

1,488

$108K

126
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $61

MOHAMMAD AL-KHARRAT M.D.

Internal Medicine

1,493

$75.3K

168
101 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

HELENA SAGALOVSKY MD

Internal Medicine

1,495

$92.6K

113
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

STEVEN MILLER M.D.

Internal Medicine

1,517

$149K

145
115 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$98
Average prescription price

Avg: $61

LARISSA DAY WALZ MD

Internal Medicine

1,527

$79K

116
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

JEFFREY GATZ MD

Internal Medicine

1,533

$71.9K

98
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $61

SEAN KELLER

Internal Medicine

1,539

$93.2K

86
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

JENNIFER DRANCIK MD

Internal Medicine

1,551

$95.6K

251
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

HUNG VO D.O.

Internal Medicine

1,576

$139K

220
159 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$88
Average prescription price

Avg: $61

KEVIN MCCALLUM MD

Internal Medicine

1,595

$125K

92
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank